Linde India

Linde India (LINDEINDIA) closed at ₹6,769.50 on 2026-11-06, marking a sharp +7.3% daily gain accompanied by extreme volume expansion (volume ratio of 11.24). This surge has positioned the stock near the upper end of its recent trading range (+79.3% in the 20-day and 50-day ranges), with immediate resistance at ₹6,863.98 (+1.4%) and ₹6,990.59 (+3.27%). On the daily chart, price action is structurally bullish, trading above all key moving averages (EMA/SMA 20/50/200) and the Supertrend indicator, supported by a developing trend strength (ADX 24.26) and strong directional movement (+DI 39.84 vs -DI 11.81). However, this short-term momentum contrasts with longer-term structures: the weekly and monthly Supertrends remain bearish, and ADX readings on those timeframes are weak to developing (16.46 and 20.02 respectively), suggesting the broader trend has not yet confirmed a reversal. The stock remains in a significant long-term drawdown (-13.7% from available high) despite positive year-to-date returns (+14.6%). Participation is evident, with five positive attention events recorded over the last 30 days. A sustained break above ₹6,990.59 with continued volume would be required to validate a shift toward a more robust multi-timeframe uptrend.

Linde India’s seven-day window (November 3–6, 2026) was defined by a divergence between operational performance and regulatory scrutiny. On November 3, the company reported Q2 results showing revenue growth of 12.3% to ₹723 crore, offset by a sharp 30.5% decline in net profit to ₹119 crore. This profit contraction coincided with an EBITDA drop of 18% to ₹232 crore and a significant margin compression of 1,200 basis points to 32%, indicating substantial pressure on profitability despite top-line expansion.

Simultaneously, legal developments intensified on November 6 when the Supreme Court directed Linde India to share a valuation report with SEBI regarding its transaction with Praxair. This order escalates an ongoing dispute over whether the arrangement constitutes a material related-party transaction requiring minority shareholder approval—a condition previously rejected by 89.23% of shareholders in March 2026. The directive follows a December 2025 Securities Appellate Tribunal ruling that upheld SEBI’s initial directions against the company. While media reports attributed a 12% share price jump to this judicial development, the core uncertainty remains the final resolution of the regulatory classification and its implications for corporate governance and potential future approvals.

Linde India shares rose 12% to ₹6,769.50 on November 6, 2026, driven by a Supreme Court directive requiring the company to share a valuation report with SEBI regarding its transaction with Praxair. This intensifies an ongoing regulatory dispute over whether the arrangement qualifies as a material related-party transaction, which would mandate minority shareholder approval. Such approval was previously rejected by 89.23% of shareholders in March 2026. The legal pressure follows a December 2025 ruling where the Securities Appellate Tribunal upheld SEBI's directions against Linde India. While the price action reflects immediate market reaction to the court order, the core issue remains unresolved: the classification of the transaction and the potential need for renewed shareholder consent.

Linde India Limited’s Board approved unaudited financial results for the half-year ended September 30, 2026, reporting revenue from operations of ₹14,175.60 million and ₹7,231.97 million for the respective periods. Concurrently, the company completed the acquisition of two 1800 TPD Air Separation Units (ASUs) from Tata Steel Limited at Kalinganagar on September 30, 2026, commencing immediate industrial gas supply to the client. These operational milestones are accompanied by significant regulatory developments: a Supreme Court hearing regarding a valuation report for a joint venture with Praxair India Private Limited is scheduled for November 6, 2026, following SEBI directives on related party transaction materiality. Additionally, shareholder approval for certain related party transactions was previously rejected at an Extraordinary General Meeting on March 5, 2026.

Linde India demonstrates a robust operating trajectory with sales expanding 12% year-on-year to ₹723 crore in the September 2026 quarter, while sequential revenue growth continued into Q1 FY2026-27 at ₹700 crore. Operating profit remained resilient at ₹232 crore for the Sep 2026 quarter, down from the peak of ₹282 crore in Sep 2025 but supported by strong cash generation; CFO/EBITDA conversion improved to 109% in FY2026. Earnings quality is evident as net profit per share rose to ₹13.48 in Sep 2026 from ₹12.24 a year prior, despite a TTM profit growth dip of -2%. The balance sheet reflects significant capacity expansion: Fixed Assets surged to ₹3,553 crore and total assets reached ₹6,766 crore as of Sep 2026, funded partly by increased borrowings (₹1,026 crore) and higher liabilities (₹2,378 crore). Capital Work In Progress decreased to ₹1,091 crore, indicating asset capitalization. Cash reserves doubled to ₹205 crore, providing liquidity. ROCE held steady at 18% in FY2026, and promoter holding remained stable at 75%. The key checkpoint is monitoring whether the expanded asset base translates into sustained margin recovery and debt servicing efficiency in upcoming quarters.

Linde India faces a dual pressure of deteriorating operational profitability and intensifying regulatory scrutiny. In Q2, net profit contracted by 30.5% year-on-year to ₹119 crore, despite revenue growth of 12.3% to ₹723 crore. This divergence highlights significant margin erosion, with EBITDA falling 18% to ₹232 crore as the margin rate dropped by 1,200 basis points to 32%. Concurrently, the company is embroiled in a regulatory dispute regarding related-party transactions with Praxair. Following a December 2025 Securities Appellate Tribunal ruling upholding SEBI’s directions, the Supreme Court has directed Linde India to share a valuation report with SEBI. The core issue remains whether the arrangement qualifies as material, requiring minority shareholder approval—a condition previously rejected by 89.23% of shareholders in March 2026. On the technical front, the stock trades at ₹6,769.50, reflecting a current drawdown of -13.7% from its peak, with monthly and weekly trends indicating bearish momentum.